FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the Wachovia Healthcare Research Conference. The presentation will take place in the Lafite Room of the Langham Hotel in Boston, Mass. on Thursday, January 31 at 8:00 a.m. Eastern Standard Time.
